{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T21:19:25Z","timestamp":1763414365154,"version":"3.45.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Skin and soft tissue infections (SSTIs) cause an increasing demand for inpatient and outpatient medical care. In recent years, health systems have promoted strategies to treat selected patients on an outpatient basis, which may avoid hospital admissions and associated complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective, cohort study of adults presenting to the emergency department (ED) with a SSTI between 2018 and 2020. Primary objective: to compare clinical outcomes in patients with SSTI treated as outpatients or inpatients. Primary outcome: Early clinical failure. Secondary outcomes: Recurrences, unplanned readmissions and ED visits related to the SSTI. Secondary objective: to investigate factors associated with eligibility for early discharge of inpatients. Logistic regression analysis was used to control for confounding factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Three hundred twenty patients were included, 160 hospitalized. The median hospital stay was 9 days (IQR 5\u201315), and 20 patients (12.5%) were discharged within 72\u00a0h after admission. In multivariate analysis, no differences were observed between groups in rates of early clinical failure, recurrences and unplanned readmissions. Hospitalized patients were significantly less likely to revisit the emergency department for SSTI-related issues (OR 0.32, 95% CI 0.16\u20130.62;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001). Social and economic barriers to medical care were associated with lower probability of being eligible for early discharge (OR 0.19 95% CI 0.07\u20130.54;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002). The severity of the infection was associated with failure to meet the eligibility criteria for early discharge (OR 0.92 95% CI 0.88\u20130.96;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>There were no differences in early clinical failure between admitted and non-admitted patients. Social and economic barriers to medical care and severity of infection were associated with not fulfilling the criteria for eligibility for early discharge.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-025-11883-6","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T18:12:38Z","timestamp":1763403158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Inpatient versus outpatient management of community-acquired acute skin and soft tissue infections. Clinical outcomes and factors associated with eligibility for early discharge"],"prefix":"10.1186","volume":"25","author":[{"given":"Elena","family":"Sendra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"L\u00f3pez-Montesinos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estela","family":"Membrilla-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Mar\u00eda","family":"Gonzalez-Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisca","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esperanza","family":"Ca\u00f1as-Ruano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Casta\u00f1eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Poblet-Florentin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosana","family":"Sabat\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Rodr\u00edguez-Alarc\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Esteban-Cuc\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amaya","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soukaina Sara","family":"Alanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Duran-Jord\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adri\u00e1n","family":"Vizoso-Exp\u00f3sito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"G\u00f3mez-Zorrilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Pablo","family":"Horcajada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"issue":"2","key":"11883_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/QCO.0000000000000906","volume":"36","author":"E Bouza","year":"2023","unstructured":"Bouza E, Burillo A, Mu\u00f1oz P. How to manage skin and soft-tissue infections in the emergency department. Curr Opin Infect Dis. 2023;36(2):81\u20138.","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"11883_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2022.106637","volume":"60","author":"AP Grossi","year":"2022","unstructured":"Grossi AP, Ruggieri A, Vecchio A, Del Comandini A, Corio L, Calisti F, et al. Skin infections in Europe: a retrospective study of incidence, patient characteristics and practice patterns. Int J Antimicrob Agents. 2022;60(3):106637.","journal-title":"Int J Antimicrob Agents"},{"key":"11883_CR3","doi-asserted-by":"crossref","unstructured":"Peterson RA, Polgreen LA, Cavanaugh JE, Polgreen PM. Increasing Incidence, Cost, and seasonality in patients hospitalized for cellulitis. Open Forum Infect Dis. 2017 Feb 8;4(1)ofx008.","DOI":"10.1093\/ofid\/ofx008"},{"issue":"Supplement3","key":"11883_CR4","doi-asserted-by":"publisher","first-page":"S193","DOI":"10.1093\/cid\/ciz002","volume":"68","author":"KS Kaye","year":"2019","unstructured":"Kaye KS, Petty LA, Shorr AF, Zilberberg MD. Current Epidemiology, Etiology, and burden of acute skin infections in the united States. Clin Infect Dis. 2019;68(Supplement3):S193\u20139.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"11883_CR5","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/QCO.0000000000000907","volume":"36","author":"M Falcone","year":"2023","unstructured":"Falcone M, Tiseo G. Skin and soft tissue infections in the elderly. Curr Opin Infect Dis. 2023;36(2):102\u20138.","journal-title":"Curr Opin Infect Dis"},{"issue":"6","key":"11883_CR6","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1177\/12034754211004558","volume":"25","author":"M Adly","year":"2021","unstructured":"Adly M, Woo TE, Traboulsi D, Klassen D, Hardin J. Understanding dermatologic concerns among persons experiencing homelessness: a scoping review and discussion for improved delivery of care. J Cutan Med Surg. 2021;25(6):616\u201326.","journal-title":"J Cutan Med Surg"},{"issue":"7","key":"11883_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac197","volume":"9","author":"S Dellsperger","year":"2022","unstructured":"Dellsperger S, Kramer S, Stoller M, Burger A, Geissb\u00fchler E, Amsler I, et al. Early switch from intravenous to oral antibiotics in skin and soft tissue infections: an algorithm-based prospective multicenter pilot trial. Open Forum Infect Dis. 2022;9(7):ofac197.","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"11883_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2024.107263","volume":"64","author":"SA Mohammed","year":"2024","unstructured":"Mohammed SA, Roberts JA, Cotta MO, Rogers B, Pollard J, Assefa GM, et al. Safety and efficacy of outpatient parenteral antimicrobial therapy: a systematic review and meta-analysis of randomized clinical trials. Int J Antimicrob Agents. 2024;64(2):107263.","journal-title":"Int J Antimicrob Agents"},{"key":"11883_CR9","doi-asserted-by":"crossref","unstructured":"Tran TT, Gomez Villegas S, Aitken SL, Butler-Wu SM, Soriano A, Werth BJ et al. New perspectives on antimicrobial agents: Long-Acting lipoglycopeptides. Antimicrob Agents Chemother. 2022 Jun 21;66(6)(6):e0261420.","DOI":"10.1128\/aac.02614-20"},{"key":"11883_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108465","volume":"126","author":"A Hazen","year":"2021","unstructured":"Hazen A, Pizzicato L, Hom J, Johnson C, Viner KM. Association between discharges against medical advice and readmission in patients treated for drug injection-related skin and soft tissue infections. J Subst Abuse Treat. 2021;126:108465.","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"11883_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10096-003-0902-x","volume":"22","author":"J Carratal\u00e0","year":"2003","unstructured":"Carratal\u00e0 J, Ros\u00f3n B, Fern\u00e1ndez-Sab\u00e9 N, Shaw E, del Rio O, Rivera A, et al. Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis. Eur J Clin Microbiol Infect Dis. 2003;22(3):151\u20137.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"11883_CR12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.eimc.2016.02.030","volume":"35","author":"C Mac\u00eda-Rodr\u00edguez","year":"2017","unstructured":"Mac\u00eda-Rodr\u00edguez C, Alende-Castro V, Vazquez-Ledo L, Novo-Veleiro I, Gonz\u00e1lez-Quintela A. Skin and soft-tissue infections: factors associated with mortality and re-admissions. Enferm Infecc Microbiol Clin. 2017;35(2):76\u201381.","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"1","key":"11883_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5811\/westjem.2014.11.24133","volume":"16","author":"D Talan","year":"2015","unstructured":"Talan D, Salhi B, Moran G, Mower W, Hsieh YH, Krishnadasan A, et al. Factors associated with the decision to hospitalize emergency department patients with a skin and soft tissue infection. West J Emerg Med. 2015;16(1):89\u201397.","journal-title":"West J Emerg Med"},{"issue":"1","key":"11883_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ajem.2018.04.046","volume":"37","author":"B Cieri","year":"2019","unstructured":"Cieri B, Conway EL, Sellick JA, Mergenhagen KA. Identification of risk factors for failure in patients with skin and soft tissue infections. Am J Emerg Med. 2019;37(1):48\u201352.","journal-title":"Am J Emerg Med"},{"issue":"5","key":"11883_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"issue":"5","key":"11883_CR16","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1097\/CCM.0b013e31819def97","volume":"37","author":"AE Jones","year":"2009","unstructured":"Jones AE, Trzeciak S, Kline JA. The sequential organ failure assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation*. Crit Care Med. 2009;37(5):1649\u201354.","journal-title":"Crit Care Med"},{"issue":"2","key":"11883_CR17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/SHK.0b013e318182f98f","volume":"31","author":"JY Rhee","year":"2009","unstructured":"Rhee JY, Kwon KT, Ki HK, Shin SY, Jung DS, Chung DR, et al. Scoring systems for prediction of mortality in patients with intensive care unit-acquired sepsis. Shock. 2009;31(2):146\u201350.","journal-title":"Shock"},{"key":"11883_CR18","unstructured":"Guidance for industry acute bacterial skin and skin structure infections: Developing drugs for treatment. 2013. Available from: https:\/\/www.fda.gov\/drugs\/guidance-compliance-regulatory-information\/guidances-drugs. Cited 2 Aug 2024."},{"issue":"2","key":"11883_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.semreu.2011.12.005","volume":"13","author":"P Parra Caballero","year":"2012","unstructured":"Parra Caballero P, P\u00e9rez Esteban S, Pati\u00f1o Ruiz ME, Casta\u00f1eda Sanz S, Garc\u00eda Vadillo JA. Actualizaci\u00f3n en fascitis necrotizante. Seminarios de la Fundaci\u00f3n Espa\u00f1ola de Reumatolog\u00eda. 2012;13(2):41\u20138.","journal-title":"Seminarios de la Fundaci\u00f3n Espa\u00f1ola de Reumatolog\u00eda"},{"issue":"8","key":"11883_CR20","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801.","journal-title":"JAMA"},{"issue":"2","key":"11883_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/QCO.0000000000000642","volume":"33","author":"F Barbier","year":"2020","unstructured":"Barbier F, Timsit JF. Risk stratification for multidrug-resistant bacteria in patients with skin and soft tissue infection. Curr Opin Infect Dis. 2020;33(2):137\u201345.","journal-title":"Curr Opin Infect Dis"},{"issue":"5","key":"11883_CR22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1001\/jamasurg.2013.173","volume":"148","author":"EZ Keung","year":"2013","unstructured":"Keung EZ, Liu X, Nuzhad A, Adams C, Ashley SW, Askari R. Immunocompromised status in patients with necrotizing soft-tissue infection. JAMA Surg. 2013;148(5):419.","journal-title":"JAMA Surg"},{"key":"11883_CR23","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 13.0. 2023. http:\/\/www.eucast.org."},{"key":"11883_CR24","doi-asserted-by":"crossref","unstructured":"Stevens DL et al. Clin Infect Dis (2014; 59:147\u201359). Clinical Infectious Diseases. 2015;60(9):1448\u20131448.","DOI":"10.1093\/cid\/civ114"},{"issue":"1","key":"11883_CR25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/emermed-2016-205950","volume":"35","author":"JW Abetz","year":"2018","unstructured":"Abetz JW, Adams NG, Mitra B. Skin and soft tissue infection management failure in the emergency department observation unit: a systematic review. Emerg Med J. 2018;35(1):56\u201361.","journal-title":"Emerg Med J"},{"issue":"Suppl1","key":"11883_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.37201\/req\/s01.10.2023","volume":"36","author":"R Blanes Hern\u00e1ndez","year":"2023","unstructured":"Blanes Hern\u00e1ndez R, Rodr\u00edguez P\u00e9rez M, Fern\u00e1ndez Navarro J, Salavert Llet\u00ed M. Current approach to skin and soft tissue infections. Thinking about continuity of care. Rev Esp Quimioter. 2023;36(Suppl1):37\u201345.","journal-title":"Rev Esp Quimioter"},{"issue":"1","key":"11883_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s13017-018-0219-9","volume":"13","author":"M Sartelli","year":"2018","unstructured":"Sartelli M, Guirao X, Hardcastle TC, Kluger Y, Boermeester MA, Ra\u015fa K, et al. 2018 WSES\/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections. World J Emerg Surg. 2018;13(1):58.","journal-title":"World J Emerg Surg"},{"issue":"2","key":"11883_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.4103\/0976-500X.130042","volume":"5","author":"JM Cyriac","year":"2014","unstructured":"Cyriac JM, James E. Switch over from intravenous to oral therapy: a concise overview. J Pharmacol Pharmacother. 2014;5(2):83\u20137.","journal-title":"J Pharmacol Pharmacother"},{"key":"11883_CR29","doi-asserted-by":"crossref","unstructured":"Bookstaver PB, Jenkins TC, Stenehjem E, Doron S, Brown J, Goldwater SH et al. Impact of outpatient vs inpatient ABSSSI treatment on outcomes: A retrospective observational analysis of medical charts across US emergency departments. Open Forum Infect Dis. 2018 May 15;5(7)ofy109.","DOI":"10.1093\/ofid\/ofy109"},{"issue":"4","key":"11883_CR30","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s40121-018-0212-3","volume":"7","author":"KC Claeys","year":"2018","unstructured":"Claeys KC, Zasowski EJ, Lagnf AM, Sabagha N, Levine DP, Davis SL, et al. Development of a risk-scoring tool to determine appropriate level of care in acute bacterial skin and skin structure infections in an acute healthcare setting. Infect Dis Ther. 2018;7(4):495\u2013507.","journal-title":"Infect Dis Ther"},{"key":"11883_CR31","doi-asserted-by":"crossref","unstructured":"Gon\u00e7alves-Bradley DC, Lannin NA, Clemson L, Cameron ID, Shepperd S. Discharge planning from hospital. Cochrane Database Syst Reviews. 2022 Feb 24;2(2):CD000313.","DOI":"10.1002\/14651858.CD000313.pub6"},{"key":"11883_CR32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.drugalcdep.2016.11.029","volume":"171","author":"S Larney","year":"2017","unstructured":"Larney S, Peacock A, Mathers BM, Hickman M, Degenhardt L. A systematic review of injecting-related injury and disease among people who inject drugs. Drug Alcohol Depend. 2017;171:39\u201349.","journal-title":"Drug Alcohol Depend"},{"key":"11883_CR33","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.drugalcdep.2019.01.037","volume":"198","author":"DL Biancarelli","year":"2019","unstructured":"Biancarelli DL, Biello KB, Childs E, Drainoni M, Salhaney P, Edeza A, et al. Strategies used by people who inject drugs to avoid stigma in healthcare settings. Drug Alcohol Depend. 2019;198:80\u20136.","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"11883_CR34","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1111\/dar.13525","volume":"41","author":"FJ Langham","year":"2022","unstructured":"Langham FJ, Curtis SJ, Tang MJ, Jomon B, Doyle JS, Vujovic O, et al. Acute injection-related infections requiring hospitalisation among people who inject drugs: clinical features, microbiology and management. Drug Alcohol Rev. 2022;41(7):1543\u201353.","journal-title":"Drug Alcohol Rev"},{"issue":"12","key":"11883_CR35","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.2105\/AJPH.2015.302885","volume":"105","author":"L Ti","year":"2015","unstructured":"Ti L, Ti L. Leaving the hospital against medical advice among people who use illicit drugs: a systematic review. Am J Public Health. 2015;105(12):e53-9.","journal-title":"Am J Public Health"},{"issue":"2","key":"11883_CR36","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s40264-015-0374-9","volume":"39","author":"MW Dunne","year":"2016","unstructured":"Dunne MW, Talbot GH, Boucher HW, Wilcox M, Puttagunta S. Safety of dalbavancin in the treatment of skin and skin structure infections: a pooled analysis of randomized, comparative studies. Drug Saf. 2016;39(2):147\u201357.","journal-title":"Drug Saf"},{"key":"11883_CR37","doi-asserted-by":"crossref","unstructured":"Vazquez Deida AA, Shihadeh KC, Preslaski CR, Young HL, Wyles DL, Jenkins TC. Use of a standardized Dalbavancin approach to facilitate earlier hospital discharge for vulnerable patients receiving prolonged inpatient antibiotic therapy. Open Forum Infect Dis. 2020 Jul 13;7(8):ofaa293.","DOI":"10.1093\/ofid\/ofaa293"},{"issue":"3","key":"11883_CR38","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ijantimicag.2015.07.001","volume":"46","author":"DN Williams","year":"2015","unstructured":"Williams DN, Baker CA, Kind AC, Sannes MR. The history and evolution of outpatient parenteral antibiotic therapy (OPAT). Int J Antimicrob Agents. 2015;46(3):307\u201312.","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"11883_CR39","doi-asserted-by":"publisher","first-page":"291","DOI":"10.37201\/req\/134.2022","volume":"36","author":"M Mir\u00f3n-Rubio","year":"2023","unstructured":"Mir\u00f3n-Rubio M, Parra Jord\u00e1n JJ, Gonz\u00e1lez Ramallo VJ, Mujal Mart\u00ednez A, Fern\u00e1ndez Muix\u00ed J, Iglesias Gallego M, et al. Economic burden of skin and skin structure infections due to gram-positive bacteria in patients on hospital at home-based outpatient parenteral antibiotic therapy (OPAT). Rev Esp Quimioter. 2023;36(3):291\u2013301.","journal-title":"Rev Esp Quimioter"},{"issue":"1","key":"11883_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2569-4","volume":"17","author":"M Chan","year":"2017","unstructured":"Chan M, Ooi CK, Wong J, Zhong L, Lye D. Role of outpatient parenteral antibiotic therapy in the treatment of community acquired skin and soft tissue infections in Singapore. BMC Infect Dis. 2017;17(1):474.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"11883_CR41","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.ijantimicag.2011.05.008","volume":"38","author":"RA Seaton","year":"2011","unstructured":"Seaton RA, Sharp E, Bezlyak V, Weir CJ. Factors associated with outcome and duration of therapy in outpatient parenteral antibiotic therapy (OPAT) patients with skin and soft-tissue infections. Int J Antimicrob Agents. 2011;38(3):243\u20138.","journal-title":"Int J Antimicrob Agents"},{"key":"11883_CR42","doi-asserted-by":"crossref","unstructured":"Ong BS, Ngian VJJ, Yeong C, Keighley C. <p>Out Of Hospital And In Hospital Management Of Cellulitis Requiring Intravenous Therapy<\/p>. Int J Gen Med. 2019;12:447\u201353.\u00a0","DOI":"10.2147\/IJGM.S230054"},{"issue":"1","key":"11883_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s40360-018-0240-3","volume":"19","author":"V Huang","year":"2018","unstructured":"Huang V, Ruhe JJ, Lerner P, Fedorenko M. Risk factors for readmission in patients discharged with outpatient parenteral antimicrobial therapy: a retrospective cohort study. BMC Pharmacol Toxicol. 2018;19(1):50.","journal-title":"BMC Pharmacol Toxicol"},{"key":"11883_CR44","doi-asserted-by":"crossref","unstructured":"Suzuki J, Johnson J, Montgomery M, Hayden M, Price C. Outpatient parenteral antimicrobial therapy among people who inject drugs: a review of the literature. Open Forum Infect Dis. 2018 Aug 7;5(9):ofy194.","DOI":"10.1093\/ofid\/ofy194"},{"key":"11883_CR45","doi-asserted-by":"crossref","unstructured":"Buehrle DJ, Shields RK, Shah N, Shoff C, Sheridan K. Risk factors associated with outpatient parenteral antibiotic therapy program failure among intravenous drug users. Open Forum Infect Dis. 2017 May 23;4(3)ofx102.","DOI":"10.1093\/ofid\/ofx102"},{"issue":"1","key":"11883_CR46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.diagmicrobio.2006.05.009","volume":"57","author":"GJ Moet","year":"2007","unstructured":"Moet GJ, Jones RN, Biedenbach DJ, Stilwell MG, Fritsche TR. Contemporary causes of skin and soft tissue infections in North America, Latin America, and europe: report from the SENTRY antimicrobial surveillance program (1998\u20132004). Diagn Microbiol Infect Dis. 2007;57(1):7\u201313.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"11883_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-252","volume":"13","author":"GT Ray","year":"2013","unstructured":"Ray GT, Suaya JA, Baxter R. Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study. BMC Infect Dis. 2013;13(1):252.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"11883_CR48","doi-asserted-by":"publisher","first-page":"e1045","DOI":"10.1093\/cid\/ciaa1717","volume":"73","author":"V Vella","year":"2021","unstructured":"Vella V, Galgani I, Polito L, Arora AK, Creech CB, David MZ, et al. Staphylococcus aureus skin and soft tissue infection recurrence rates in outpatients: A retrospective database study at 3 US medical centers. Clin Infect Dis. 2021;73(5):e1045\u201353.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"11883_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204036","volume":"13","author":"J Collazos","year":"2018","unstructured":"Collazos J, de la Fuente B, Garc\u00eda A, G\u00f3mez H, Men\u00e9ndez C, Enr\u00edquez H, et al. Cellulitis in adult patients: a large, multicenter, observational, prospective study of 606 episodes and analysis of the factors related to the response to treatment. PLoS One. 2018;13(9):e0204036.","journal-title":"PLoS One"},{"issue":"1","key":"11883_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2021.101539","volume":"25","author":"RCP Leme","year":"2021","unstructured":"Leme RCP, Bispo PJM, Salles MJ. Community-genotype methicillin-resistant Staphylococcus aureus skin and soft tissue infections in Latin America: a systematic review. Braz J Infect Dis. 2021;25(1):101539.","journal-title":"Braz J Infect Dis"},{"issue":"1","key":"11883_CR51","first-page":"157","volume":"91","author":"D Cucinotta","year":"2020","unstructured":"Cucinotta D, Vanelli M WHO declares COVID-19 a pandemic.Acta Biomed. 2020; 91((1):):157\u201360.","journal-title":"Acta Biomed"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11883-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11883-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11883-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T18:12:41Z","timestamp":1763403161000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11883-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11883"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11883-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with national and international ethical guidelines, including the Deontological Code, the Declaration of Helsinki (revised in Fortaleza, Brazil, October 2013), the Code of Good Research Practices, and Royal Decree 957\/2020 of November 3rd, which regulates observational studies with human-use medicines in Spain. The study was approved by the Clinical Research Ethics Committee of the Parc de Salut Mar, Barcelona (register no. 2021\/10132). Informed consent not applicable due to the observational nature of the study in accordance with Spanish national regulations and Clinical Research Ethics Committee judgment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1594"}}